Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Lipocine Inc.tm211119d1_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - Lipocine Inc.tm211119d1_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Lipocine Inc.tm211119d1_ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - Lipocine Inc.tm211119d1_ex23-1.htm
EX-21.1 - EXHIBIT 21.1 - Lipocine Inc.tm211119d1_ex21-1.htm
10-K - FORM 10-K - Lipocine Inc.tm211119d1_10k.htm





In connection with the Annual Report on Form 10-K of Lipocine Inc. (the “Corporation”) for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Mahesh V. Patel, President and Chief Executive Officer of the Corporation, hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:


(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.


Dated: March 11, 2021     /s/ Mahesh V. Patel
      Mahesh V. Patel, President and Chief Executive Officer
      (Principal Executive Officer)